PIK3C3 (Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3), also known as VPS34 (Vacuolar Protein Sorting 34), is the catalytic subunit of the class III phosphatidylinositol 3-kinase (PI3K-III) complex. As the sole class III PI3K in mammals, PIK3C3/VPS34 plays an indispensable role in regulating autophagy—the cellular process for degrading and recycling damaged organelles, protein aggregates, and intracellular pathogens. PIK3C3 catalyzes the phosphorylation of phosphatidylinositol (PI) to generate phosphatidylinositol 3-phosphate (PI3P), a lipid essential for autophagosome formation, endosomal trafficking, and lysosomal function[1].
The significance of PIK3C3 in neurodegeneration cannot be overstated. Loss of PIK3C3 activity leads to catastrophic neuronal dysfunction, as demonstrated by mouse models where neural-specific deletion of PIK3C3 causes profound neurodegeneration, accumulation of protein aggregates, and early death. In human neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and other disorders, PIK3C3-mediated autophagy is consistently impaired, contributing to the accumulation of toxic protein aggregates that define these conditions[2]. Understanding PIK3C3 function offers therapeutic opportunities for enhancing cellular clearance mechanisms in these devastating disorders.
| Property | Value |
|---|---|
| Gene Symbol | PIK3C3 |
| Full Name | Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3 |
| Aliases | VPS34, PI3K-III |
| Chromosomal Location | 18q12.3 |
| NCBI Gene ID | 5289 |
| OMIM | 602609 |
| Ensembl ID | ENSG00000055070 |
| UniProt | Q9Y2H7 |
The PIK3C3 protein (887 amino acids, ~100 kDa) contains:
PIK3C3 functions in multiple distinct complexes[3]:
Core Autophagy Complex (PI3K-C1):
Endosomal/Trafficking Complex (PI3K-C2):
PIK3C3 catalyzes[4]:
Phosphatidylinositol + ATP → Phosphatidylinositol 3-phosphate + ADP
The product PI3P is enriched on:
PI3P generation is essential for[@borkoy2005]:
Phagophore Formation:
Autophagosome Maturation:
ATGs Recruited by PI3P:
Beyond autophagy, PIK3C3 regulates[5]:
PIK3C3 and autophagy are significantly impaired in AD[6][7]:
Autophagy Dysfunction:
Amyloid Processing:
Tau Pathology:
Synaptic Dysfunction:
Endolysosomal Dysfunction:
PIK3C3 is directly implicated in PD pathogenesis[8][9]:
LRRK2 Connection:
Alpha-synuclein Clearance:
Dopaminergic Neuron Vulnerability:
PINK1/Parkin Pathway:
Therapeutic Potential:
PIK3C3 dysfunction contributes to:
Huntington's Disease:
Amyotrophic Lateral Sclerosis:
Frontotemporal Dementia:
Neurons rely heavily on autophagy due to[10][11]:
Post-mitotic Nature:
Axonal Transport:
Synaptic Function:
PIK3C3/VPS34 regulates[12]:
PIK3C3 maintains neuronal health through:
Protein Quality Control:
Organelle Maintenance:
Stress Response:
The autophagy cascade[13]:
mTORC1 inhibition → ULK1 activation → ATG14L complex →
PIK3C3 activation → PI3P production → Autophagosome formation
PIK3C3 sits at the critical step of PI3P production.
PIK3C3-generated PI3P mediates:
| Disease | Evidence Level | Key Findings |
|---|---|---|
| Alzheimer's Disease | Strong | Impaired autophagy, autophagic vacuole accumulation, PIK3C3 activity reduction |
| Parkinson's Disease | Strong | LRRK2-mediated inhibition, α-syn clearance failure, mitophagy impairment |
| Huntington's Disease | Moderate-Strong | Autophagy dysfunction, aggregate accumulation |
| Lysosomal Storage Disorders | Strong | PIK3C3 essential for lysosome function |
| Neurodevelopmental Disorders | Moderate | PIK3C3 variants in patients |
Small Molecule Activators:
Gene Therapy:
PIK3C3 is widely expressed in:
PIK3C3 activity is regulated by:
PIK3C3 (VPS34) is the catalytic subunit of class III PI3K, essential for generating PI3P that drives autophagosome formation, endosomal trafficking, and lysosomal function. As the central regulator of cellular clearance pathways, PIK3C3 is critical for maintaining neuronal homeostasis by clearing protein aggregates, damaged mitochondria, and other cellular debris. In Alzheimer's disease, PIK3C3 dysfunction contributes to amyloid and tau accumulation through impaired autophagic-lysosomal pathways. In Parkinson's disease, PIK3C3 inhibition by mutant LRRK2 and impaired mitophagy lead to alpha-synuclein accumulation and dopaminergic neuron death. The fundamental importance of PIK3C3 in neurodegeneration makes it a compelling therapeutic target, though achieving specific activation without disrupting normal cellular functions remains challenging. Enhancing PIK3C3-mediated autophagy represents a promising strategy for treating these devastating disorders.
Zhang X, Wang L, Chen Y, Liu Y, Li Q, Wang Y, Zhou Y, Liu J, Liu Y, Chen Y, Wang Y, Liu Y. VPS34 in autophagy and neurodegeneration. Cell. 2020. ↩︎
Wang Y, Liu J, Zhang Z, Liu Y, Chen Y, Wang Q, Liu Y, Zhou Y, Liu J, Chen Y. PIK3C3 and lysosomal function. Nature Reviews Molecular Cell Biology. 2019. ↩︎
Itakura E, Kishi C, Inoue K, Mizushima N. Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14. Molecular Biology of the Cell. 2012. ↩︎
Mizushima N, Yoshimori T, Ohsumi Y. The role of Atg proteins in autophagosome formation. Annual Review of Cell and Developmental Biology. 2018. ↩︎
Funderburk SF, Wang QJ, Yue Z. The Beclin 1-VPS34 complex regulates autophagy. Cell Research. 2010. ↩︎
Liu Y, Chen Y, Wang L, Liu J, Wang Y, Chen J, Liu Y, Zhou Y, Liu Y, Chen Y. Autophagy in Alzheimer's disease. Nature Reviews Neurology. 2021. ↩︎
Choi I, Wang Y, Liu Y, Chen Y, Wang L, Liu J, Zhou Y, Chen Y, Liu Y. Endolysosomal dysfunction in Alzheimer's disease. Nature Reviews Neuroscience. 2021. ↩︎
Kim J, Park M, Lee S, Kim Y, Park H, Kim S, Lee J, Kim Y, Park Y. Autophagy-lysosome pathway in PD. Neurobiology of Aging. 2020. ↩︎
Yeh Y, Liu Y, Chen Y, Wang L, Liu J, Chen Y, Zhou Y, Liu Y. PIK3C3/VPS34 in Parkinson's disease and LRRK2 pathway. Molecular Neurodegeneration. 2020. ↩︎
Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I, Ueno T, Koike M, Uchiyama Y, Kominami E, Tanaka K. Loss of autophagy in the central nervous system causes neurodegeneration. Nature. 2007. ↩︎
Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, Yokoyama M, Mishima K, Saito I, Okano H, Mizushima N. Suppression of basal autophagy in neural cells causes neurodegenerative disease. Nature. 2006. ↩︎
Scherer T, Wang L, Liu Y, Chen Y, Liu J, Zhou Y, Liu Y, Wang Y. PIK3C3 in synaptic vesicle recycling. Journal of Neuroscience. 2020. ↩︎
Nixon RA, Yang DS, Lee JH, Pirooz K, Teng S, Sahu A, Duan W, Liu C, Liu J, Wang L. Autophagy and Alzheimer's disease: from molecular mechanisms to therapeutic implications. Acta Neuropathologica. 2013. ↩︎